The use of COA in patient-centered drug development: part 2
This week, we're putting the PRO in PROgress by discussing Patient Reported Outcomes with guests Paul Miller and Olivier Wong. In particular, how they're shaping the world of health technology assessment.
The use of COA in patient-centered drug development: part 2
This week, we're putting the PRO in PROgress by discussing Patient Reported Outcomes with guests Paul Miller and Olivier Wong. In particular, how they're shaping the world of health technology assessment.